“…Because macrovascular and microvascular complications can start to develop with even mild hyperglycemia, clinicians should screen individuals as early as possible before DM symptoms occur. Several studies support the use of a diabetes risk tool as a reliable and valid tool to detect undiagnosed DM and PreDM with a sensitivity and specificity range of 77–83% and 65–72%, respectively (Franciosi et al, 2005; Heikes et al, 2008; Lindstrom & Tuomilehto, 2003; Ojo et al, 2020; World Health Organization, 2003). Woo et al (2017) completed a long-term cohort study that found the adoption of the ADA Diabetes Risk Test to be generalizable and straightforward with high specificity, positive predictive value, and positive likelihood ratio, allowing for fewer individuals needing more invasive testing.…”